Back to search

Article

MS275 induces tumor immunosuppression by up-regulating PD-L1 and enhances the efficacy of anti-PD-1 immunotherapy in colorectal cancer

2024-03-22

Abstract excerpt

<title>Abstract</title> <p>The histone deacetylase inhibitor MS275 (Entinostat) demonstrates anti-tumor effects against various types of solid tumors <italic>in vitro</italic>. But its effectiveness in clinical trials is limited. The underlying reasons remain to be determined. The purpose of this study was to explore how to enhance the anti-tumor effects of MS275 in colorectal cancer(CRC). Our data showed that MS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
92c75a57-2065-5d05-8a9f-886c15338ce6
DOI
10.21203/rs.3.rs-4133957/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MS275 induces tumor immunosuppression by up-regulating PD-L1 and enhances the efficacy of anti-PD-1 immunotherapy in colorectal cancerDOI 10.21203/rs.3.rs-4133957/v1
Select a neighboring publication to make it the new centre.